SMTL ID : 4cfu.1 (1 other biounit)

Structure-based design of C8-substituted O6-cyclohexylmethoxyguanine CDK1 and 2 inhibitors.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

hetero-1-1-mer

Ligands

1 x 2WC: 3-[2-azanyl-6-(cyclohexylmethoxy)-7H-purin-8-yl]-2-methyl-benzoic acid(Non-covalent)

2WC.1: 16 residues within 4Å: Chain A: I.15, V.23, A.36, V.69, F.85, E.86, F.87, L.88, H.89, Q.90, D.91, K.94, Q.136, N.137, L.139, D.150 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:I.15, A:F.87 Hydrogen bonds: A:E.86, A:L.88, A:D.91 Water bridges: A:I.15 Salt bridges: A:K.94

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 4 residues within 4Å: Chain A: P.276, N.277, R.279 Chain B: V.2 3 PLIP interactions: 2 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:P.276, A:R.279, H2O.6

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Carbain, B. et al., 8-Substituted O6-Cyclohexylmethylguanine Cdk2 Inhibitors; Using Structure-Based Inhibitor Design to Optimise an Alternative Binding Mode. J.Med.Chem. (2014)

Release Date

2014-12-10

Peptides

CYCLIN-DEPENDENT KINASE 2: A
CYCLIN-A2: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

CYCLIN-DEPENDENT KINASE 2

CYCLIN-A2

Related Entries With Identical Sequence